Abstract:Background This study assessed trends in treatment and outcomes of anal melanomas over a 17‐year period. Methods NCDB was searched for patients with anal melanoma (2004–2020). Receiver‐operating characteristic curve analysis was used to determine cutoff year marking increased overall survival (OS) of anal melanoma. Characteristics, treatments, and outcomes in consecutive time periods were compared. Results A total of 815 patients (mean age: 67.2 years; 59.4% female) were included: 354 in Period 1 (2004–2012) and 461 in Period 2 (2013–2020). Period 2 included fewer abdominoperineal resections (18% vs. 28%, p = 0.002), more local tumor excisions (61.1% vs. 55%, p = 0.002), more often immunotherapy (odds ratio [OR]: 3.41, 95% confidence interval [CI]: 2.22–5.22, p

A national database analysis of the evolution of outcomes of surgery for anal melanoma